EOS MED CHEM CO., LTD

小間番号：4R-34

カテゴリー：原料

パビリオン：中国パビリオン

企業情報

Email： order@eosmedchem.com TEL： +86-531-6990-5422 住所： 16F, China Overseas Plaza, Jinan City, China 250024 URL： http://www.eosmedchem.com

日本におけるコンタクト先

代理店名： EOS MED CHEM CO., LTD Email： order@eosmedchem.com TEL： +86-531-6990-5422 住所：〒250024
16F, China Overseas Plaza, Jinan City, China

EOS mainly serving new drug research and development institutions including CRO institutions and scientific research institutes. The identification of candidates and other key aspects of new drug development.

EOS Medchem is big in: New API and Intermediates, Custom synthesis, ADC Drug

MG: Pharma Impurity

G: New small molecule and inhibitor

KG: New drug Intermediates

100KG: New chemical CMO

R&D Center: 4000 sq, More than 100 hoods

Pilot Plant: 20000sq, 40 reactors from 5-200L

Manufacturing Site: 800000sq, 40 reactors from 100-5000L

Web: www.eosmedchem.com

Email: info@eosmedchem.com ; eosmedchem@gmail.com;

R&D youtube: https://youtu.be/r5cJdXKNXHk

企業情報

住所	16F, China Overseas Plaza, Jinan City, China 250024
TEL	+86-531-6990-5422
FAX	+86-531-6990-5422
URL	http://www.eosmedchem.com
Email	order@eosmedchem.com

出展製品・サービス	(2460460-94-8)(2S,3R,4S,5S,6S)-2-(2-((S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanamido)propanamido)-5-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate (2925289-44-5)(S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-((3-aminophenethyl)(methyl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamide (1870916-87-2)6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-[(1S)-1-{[(1S)-1-[(4-(hydroxymethyl)phenyl)carbamoyl]ethyl]carbamoyl}-2-methylpropyl]hexanamide (2722698-01-1)tert-butyl (2-(4-amino-2-chlorophenethoxy)ethyl)(methyl)carbamate (1599440-07-9)[2-(Fmoc-amino)acetamido]Acetate-Cbz (2055041-41-1)NH-bis(PEG4-Boc);NH-bis(PEG4-t-butyl ester) (2460461-34-9)(2S,3R,4S,5S,6S)-2-(2-((S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)propanamido)-5-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate (916821-46-0)IRDye 700DX NHS Ester (1343407-91-9)Alloc-Val-Ala-PAB-OH (2050232-20-5)Belantamab Mafodotin (1346452-25-2)Enfortumab Vedotin (1313206-42-6)Polatuzumab vedotin (914088-09-8)Brentuximab vedotin (solution) (1702967-37-0)(2S)-2-({[(1S)-1-carboxy-5-[(2S)-3-(naphthalen-2-yl)-2-{[(1s,4s)-4-[(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl]cyclohexyl]formamido}propanamido]pentyl]carbamoyl}amino)pentanedioic acid (163768-52-3)benzyl (2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate (1260431-28-4)1,4-Dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone, 16-[(1S)-1-[(2R,3R)-3-[4-(aminomethyl)phenyl]-2-oxiranyl]ethyl]-10-[(3-chloro-4-methoxyphenyl)methyl]-6,6-dimethyl-3-(2-methylpropyl)-, (3S,10R,13E,16S)- (2847102-44-5)Calotatug ginistinag (1491917-83-9)Satralizumab Linker (2227102-46-5)Patritumab deruxtecan (2768350-77-0)Sacituzumab tirumotecan

出展製品・サービス

(2460460-94-8)(2S,3R,4S,5S,6S)-2-(2-((S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanamido)propanamido)-5-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 新製品

(2925289-44-5)(S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-((3-aminophenethyl)(methyl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamide 新製品

(1870916-87-2)6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-[(1S)-1-{[(1S)-1-[(4-(hydroxymethyl)phenyl)carbamoyl]ethyl]carbamoyl}-2-methylpropyl]hexanamide 新製品

(2722698-01-1)tert-butyl (2-(4-amino-2-chlorophenethoxy)ethyl)(methyl)carbamate 新製品

(1599440-07-9)[2-(Fmoc-amino)acetamido]Acetate-Cbz 新製品

(2055041-41-1)NH-bis(PEG4-Boc);NH-bis(PEG4-t-butyl ester) 新製品

(2460461-34-9)(2S,3R,4S,5S,6S)-2-(2-((S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)propanamido)-5-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 新製品

(916821-46-0)IRDye 700DX NHS Ester 新製品

(1343407-91-9)Alloc-Val-Ala-PAB-OH 新製品

(2050232-20-5)Belantamab Mafodotin 新製品

(1346452-25-2)Enfortumab Vedotin 新製品

(1313206-42-6)Polatuzumab vedotin 新製品

(914088-09-8)Brentuximab vedotin (solution) 新製品

(1702967-37-0)(2S)-2-({[(1S)-1-carboxy-5-[(2S)-3-(naphthalen-2-yl)-2-{[(1s,4s)-4-[(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl]cyclohexyl]formamido}propanamido]pentyl]carbamoyl}amino)pentanedioic acid 新製品

(163768-52-3)benzyl (2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoate 新製品

(1260431-28-4)1,4-Dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone, 16-[(1S)-1-[(2R,3R)-3-[4-(aminomethyl)phenyl]-2-oxiranyl]ethyl]-10-[(3-chloro-4-methoxyphenyl)methyl]-6,6-dimethyl-3-(2-methylpropyl)-, (3S,10R,13E,16S)- 新製品

(2847102-44-5)Calotatug ginistinag 新製品

(1491917-83-9)Satralizumab Linker 新製品

(2227102-46-5)Patritumab deruxtecan 新製品

(2768350-77-0)Sacituzumab tirumotecan 新製品